PsilodexMedication × psilocybin
Your list , 0 items
Medication class

Antihistamines and allergy pills and psilocybin.

20 records in this group. None has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.

20Records
0With human data

Also searched as antihistamine · allergy pill · allergy medicine · allergy medication

01 What the evidence covers

Best evidence available per medication
20No psilocybin data
No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts

02 Each medication

A to Z
  • Acetaminophen–diphenhydramine · Tylenol PMEvidence: No psilocybin data

    Occasional headaches and minor aches and pains with accompanying sleeplessness

    It causes drowsiness and may cause confusion with psilocybin. The acetaminophen part has no known psilocybin interaction.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Azelastine · AstelinEvidence: No psilocybin data

    Seasonal allergies (seasonal allergic rhinitis); Non-allergic runny nose (vasomotor rhinitis)

    Not studied with psilocybin; its sleepiness may add to other sedating effects. Also, its label warns against combining it with alcohol or sedatives.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Azelastine–fluticasone · DymistaEvidence: No psilocybin data

    Seasonal allergic rhinitis (ages 6 and older)

    Not studied with psilocybin; its sleepiness may add to other sedating effects.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Brompheniramine–dextromethorphan–pseudoephedrine · Bromfed DMEvidence: No psilocybin data

    Cough and upper respiratory symptoms, including nasal congestion, from allergies or the common cold

    Its ingredients act on serotonin, raise blood pressure and heart rate, and cause sedation; each may add to psilocybin's effects.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Cetirizine · ZyrtecEvidence: No psilocybin data

    Hay fever and upper respiratory allergy symptoms (runny nose, sneezing, itchy watery eyes); Hives (urticaria) and itching from hives

    Not studied with psilocybin; no linking mechanism is described. Also, it can cause dose-related sleepiness.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Cyproheptadine · PeriactinEvidence: No psilocybin data

    Allergic and nonallergic nasal symptoms (allergic and vasomotor rhinitis); Allergic eye inflammation (allergic conjunctivitis)

    It blocks the receptor psilocybin works through, so it is expected to weaken psilocybin's effects.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Dimenhydrinate · Dramamine Original Formula, Driminate, GravolEvidence: No psilocybin data

    Nausea, vomiting and dizziness of motion sickness (prevention and treatment); Vertigo of motion sickness (injection)

    Not studied with psilocybin; its marked drowsiness and dizziness may add to psilocybin's altered state and confusion.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Diphenhydramine · BenadrylEvidence: No psilocybin data

    Hay fever and upper respiratory allergy symptoms; Common cold symptoms (runny nose, sneezing)

    Its drowsiness and confusion may add to psilocybin's effects, though it has no meaningful serotonin effect. Also, it raises heart rate.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Doxylamine · Unisom SleepTabsEvidence: No psilocybin data

    Trouble falling asleep (occasional sleeplessness); Nausea and vomiting of pregnancy (with pyridoxine, Rx)

    It is sedating and may cause confusion or delirium during psilocybin's altered state.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Fexofenadine · AllegraEvidence: No psilocybin data

    Allergy symptoms (hay fever and upper respiratory allergies); Hives (urticaria): reduces hives and relieves itching

    Not studied with psilocybin; no linking mechanism is described.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Hydroxyzine · Vistaril, AtaraxEvidence: No psilocybin data

    Anxiety and tension; Itching from allergic skin conditions (hives, eczema, contact dermatitis)

    Its sleepiness and confusion may add to psilocybin's effects. Also, it can cause heart-rhythm (QT) effects, more so with other drugs that do this.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Ibuprofen–diphenhydramine · Advil PM, Motrin PMEvidence: No psilocybin data

    Occasional sleeplessness associated with minor aches and pains

    Its diphenhydramine causes drowsiness and may cause confusion under psilocybin. Also, regular ibuprofen use can raise blood pressure, as psilocybin briefly does.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Levocetirizine · XyzalEvidence: No psilocybin data

    Allergy symptoms (hay fever and other respiratory allergies); Chronic hives (chronic idiopathic urticaria), skin symptoms (Rx)

    Not studied with psilocybin; no linking mechanism is described; it can cause drowsiness and fatigue.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Loratadine · ClaritinEvidence: No psilocybin data

    Allergy symptoms (hay fever and upper respiratory allergies)

    Not studied with psilocybin; no linking mechanism is described.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Loratadine–pseudoephedrine · Claritin-D 12 Hour, Claritin-D 24 Hour, Alavert Allergy and Congestion D-12Evidence: No psilocybin data

    Allergy symptoms (sneezing, runny nose, itchy or watery eyes, itchy nose or throat); Nasal and sinus congestion and pressure from colds or allergies

    Its pseudoephedrine may raise blood pressure and heart rate, adding to psilocybin's brief rise; loratadine has no known psilocybin interaction.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Meclizine · AntivertEvidence: No psilocybin data

    Motion sickness (nausea, vomiting, dizziness); Vertigo from inner-ear (vestibular) disease (prescription)

    Its sedation and confusion risk may add to psilocybin's effects.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Naproxen–diphenhydramine · Aleve PMEvidence: No psilocybin data

    Occasional sleeplessness associated with minor aches and pains

    It causes drowsiness and may cause confusion with psilocybin; regular naproxen use can raise blood pressure, as psilocybin briefly does.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Promethazine · PhenerganEvidence: No psilocybin data

    Allergic conditions (hay fever, hives, allergic eye inflammation); Severe allergic reactions (add-on to epinephrine)

    Its sedating and drying (anticholinergic) effects may add drowsiness or confusion with psilocybin. Also, it may lower the seizure threshold.

    CO: unsettled · OR: not mentioned in rule · NM: rules not final

  • Promethazine-codeine ("lean")Evidence: No psilocybin data

    Cough and upper respiratory symptoms from allergies or the common cold (adults 18+)

    Not studied with psilocybin; with other sedatives, it can cause deep sedation and slowed breathing. Stopping it suddenly after regular use can cause withdrawal.

    CO: unsettled · OR: not mentioned in rule · NM: rules not final

  • Promethazine–dextromethorphan · Promethazine DMEvidence: No psilocybin data

    Cough and upper respiratory symptoms with allergy or the common cold

    Its promethazine is sedating and drying, so it may add drowsiness or confusion with psilocybin. Its dextromethorphan may add serotonin effects.

    CO: unsettled · OR: not mentioned in rule · NM: rules not final

03 Properties the records flag

Records with each flag
17Sedating or CNS depressant
13Anticholinergic
4Raises blood pressure or heart rate
3Lowers seizure threshold or carries seizure risk
3Psychiatric reactions
2Dissociative (NMDA antagonist)
2Serotonergic
1Blocks 5-HT2A (may blunt effects)
1Liver injury
1Lowers blood pressure or causes orthostasis
1Opioid
1QT-prolonging
1Withdrawal or rebound if stopped abruptly

Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.

04 State rules

Official text governs
COColorado · final · checked 2026-10-24

No provision names these medications or this group. 3 unsettled.

Colorado rules 2.2(A)(6) and 2.2(A)(7) both address participants taking lithium or an antipsychotic, and the rule text does not state how the two fit together. The rule names “antipsychotic medications” without defining the term or limiting it by indication, so whether it covers this medication is unsettled; the regulator has not addressed this. Promethazine is a phenothiazine, the chemical family of several antipsychotics, and blocks dopamine D2 receptors, but it is approved for allergy, nausea, motion sickness and sedation, not for psychosis. Colorado rule 2.2(A)(6) states that Facilitator licensees may not provide natural medicine services to participants taking lithium or antipsychotic medications. Under 2.2(A)(7), services may proceed only after a referral from a licensed provider (MD, DO, APN, PA or clinical facilitator), medical clearance from the participant's provider, or a consultation and risk review with a provider licensed to diagnose and treat the condition identified as a risk factor; the Facilitator documents the consultation, and where it identifies heightened risk, the rule requires a safety plan and written informed consent.

Colorado rules 2.2(A)(6) and 2.2(A)(7) both address participants taking lithium or an antipsychotic, and the rule text does not state how the two fit together. The rule names “antipsychotic medications” without defining the term or limiting it by indication, so whether it covers this medication is unsettled; the regulator has not addressed this. This syrup contains promethazine, a phenothiazine (the chemical family of several antipsychotics) that blocks dopamine D2 receptors, but promethazine is approved for allergy, nausea and sedation, not for psychosis. Colorado rule 2.2(A)(6) states that Facilitator licensees may not provide natural medicine services to participants taking lithium or antipsychotic medications. Under 2.2(A)(7), services may proceed only after a referral from a licensed provider (MD, DO, APN, PA or clinical facilitator), medical clearance from the participant's provider, or a consultation and risk review with a provider licensed to diagnose and treat the condition identified as a risk factor; the Facilitator documents the consultation, and where it identifies heightened risk, the rule requires a safety plan and written informed consent.

Rule 2.2(A)(9): a facilitator must tell prospective participants in writing that anyone taking a psychotropic medication identified as a risk factor on the safety screen must meet one of the 2.2(A)(7) conditions. 1 of the 20 medications in this group is psychotropic; the rule applies when one is identified as a risk factor on a participant's screen.

OROregon · final · checked 2026-10-24

No provision names these medications or this group.

NMNew Mexico · pending · checked 2026-10-24

Rules not final; the proposed rules reviewed name no medication in this group.

05 Studies cited in this group

Records citing each
17Halman A, Kong G, Sarris J, Perkins D. Drug–drug interactions involving classic psychedelics: a systematic review. J Psychopharmacol 2024;38(1):3–18.
15Sarparast A, Thomas K, Malcolm B, Stauffer CS. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology 2022;239(6):1945–1976.
2Vollenweider FX, Vollenweider-Scherpenhuyzen MFI, Bäbler A, Vogel H, Hell D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. NeuroReport 1998;9:3897–3902.

Related classes

Records reviewed 2026-10-03 to 2026-10-14. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z

AgreementPsilodex

Before you use Psilodex

Check each box to continue.

Your searches, your list and the medications you look up stay in this browser. We can't see them. Privacy · Emergency: 911 · Mental health crisis: call or text 988 · Poison Control: 1-800-222-1222

Terms version 2026-10-25